0

530697

ZENLABS

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Zenlabs Ethica Limited Share Price Today

Investment Returns

Over 1 Month 13.86% Over 3 Months 80.81% Over 6 Months 75.39% Over 1 Year 3.66%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Zenlabs Ethica Limited fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 22.50
  • P/E Ratio (TTM) -11.62
  • Beta 1.04
  • Book Value / share 13.07
  • Return on equity 2.63%
  • EPS (TTM) 0.03
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.00
info icon alternate text

Zenlabs Ethica Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 10.58
Operating Expense 10.62
Net Profit 0.00
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.00
EBITDA 0.40
Effective Tax Rate (%) 100.00
Particulars DEC 2025 (Values in Cr)
Revenue 12.43
Operating Expense 12.37
Net Profit -2.01
Net Profit Margin (%) -16.17
Earnings Per Share (EPS) -3.08
EBITDA -1.54
Effective Tax Rate (%) 0.49
Particulars SEP 2025 (Values in Cr)
Revenue 12.43
Operating Expense 12.42
Net Profit 0.04
Net Profit Margin (%) 0.32
Earnings Per Share (EPS) 0.06
EBITDA 0.51
Effective Tax Rate (%) 50.00
Particulars JUN 2025 (Values in Cr)
Revenue 11.48
Operating Expense 11.44
Net Profit 0.03
Net Profit Margin (%) 0.26
Earnings Per Share (EPS) 0.05
EBITDA 0.54
Effective Tax Rate (%) 25.00
Particulars MAR 2025 (Values in Cr)
Revenue 12.99
Operating Expense 12.87
Net Profit 0.09
Net Profit Margin (%) 0.69
Earnings Per Share (EPS) 0.14
EBITDA 0.70
Effective Tax Rate (%) 37.50
Particulars MAR 2026 (Values in Cr)
Revenue 46.92
Operating Expense 46.84
Net Profit -1.94
Net Profit Margin (%) -4.13
Earnings Per Share (EPS) -2.97
EBITDA -0.10
Effective Tax Rate (%) -6.62
Particulars MAR 2025 (Values in Cr)
Revenue 51.42
Operating Expense 51.05
Net Profit 0.27
Net Profit Margin (%) 0.52
Earnings Per Share (EPS) 0.41
EBITDA 2.62
Effective Tax Rate (%) 37.20
Particulars MAR 2024 (Values in Cr)
Revenue 58.56
Operating Expense 58.28
Net Profit 0.42
Net Profit Margin (%) 0.71
Earnings Per Share (EPS) 0.65
EBITDA 2.70
Effective Tax Rate (%) 27.58
Particulars MAR 2023 (Values in Cr)
Revenue 66.89
Operating Expense 65.76
Net Profit 0.49
Net Profit Margin (%) 0.73
Earnings Per Share (EPS) 0.75
EBITDA 2.45
Effective Tax Rate (%) 28.35
Particulars MAR 2022 (Values in Cr)
Revenue 69.09
Operating Expense 67.91
Net Profit 0.82
Net Profit Margin (%) 1.18
Earnings Per Share (EPS) 1.26
EBITDA 2.52
Effective Tax Rate (%) 34.92
Particulars MAR 2025 (Values in Cr)
Book Value / Share 16.01
ROE % 2.63
ROCE % 5.32
Total Debt to Total Equity 1.34
EBITDA Margin 5.10
Particulars MAR 2024 (Values in Cr)
Book Value / Share 15.55
ROE % 4.24
ROCE % 6.51
Total Debt to Total Equity 1.04
EBITDA Margin 4.63
Particulars MAR 2023 (Values in Cr)
Book Value / Share 14.91
ROE % 9.46
ROCE % 11.42
Total Debt to Total Equity 0.51
EBITDA Margin 4.54
Particulars MAR 2022 (Values in Cr)
Book Value / Share 14.34
ROE % 8.72
ROCE % 12.25
Total Debt to Total Equity 0.36
EBITDA Margin 3.59
Particulars MAR 2021 (Values in Cr)
Book Value / Share 13.16
ROE % 9.64
ROCE % 11.52
Total Debt to Total Equity 0.21
EBITDA Margin 3.28
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.79
Total Assets 40.62
Total Liabilities 40.62
Total Equity 10.42
Share Outstanding 0
Price to Book Ratio 1.95
Return on Assets (%) 0.66
Return on Capital (%) 1.21
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.92
Total Assets 40.25
Total Liabilities 40.25
Total Equity 10.12
Share Outstanding 0
Price to Book Ratio 2.67
Return on Assets (%) 1.04
Return on Capital (%) 1.82
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.63
Total Assets 43.49
Total Liabilities 43.49
Total Equity 9.70
Share Outstanding 0
Price to Book Ratio 4.63
Return on Assets (%) 1.12
Return on Capital (%) 3.86
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.50
Total Assets 37.89
Total Liabilities 37.89
Total Equity 9.33
Share Outstanding 0
Price to Book Ratio 1.99
Return on Assets (%) 2.06
Return on Capital (%) 7.31
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.69
Total Assets 32.20
Total Liabilities 32.20
Total Equity 8.56
Share Outstanding 0
Price to Book Ratio 1.61
Return on Assets (%) 2.38
Return on Capital (%) 8.58
Particulars MAR 2025 (Values in Cr)
Net Income 0.42
Cash from Operations 4.04
Cash from Investing 0.13
Cash from Financing -3.08
Net change in Cash 0.88
Free Cash Flow 4.06
Particulars MAR 2024 (Values in Cr)
Net Income 0.58
Cash from Operations -8.93
Cash from Investing 0.10
Cash from Financing 8.23
Net change in Cash -0.71
Free Cash Flow -8.90
Particulars MAR 2023 (Values in Cr)
Net Income 0.67
Cash from Operations 1.78
Cash from Investing -1.46
Cash from Financing 0.06
Net change in Cash 0.11
Free Cash Flow 3.33
Particulars MAR 2022 (Values in Cr)
Net Income 1.22
Cash from Operations -0.25
Cash from Investing 0.00
Cash from Financing 0.31
Net change in Cash -0.06
Free Cash Flow -0.23
Particulars MAR 2021 (Values in Cr)
Net Income 0.86
Cash from Operations -8.31
Cash from Investing 0.15
Cash from Financing -0.52
Net change in Cash -8.78
Free Cash Flow -8.31
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 13.14 1.53 243.69 23.12 38.85
BLISS GVS PHARMA LTD. 486.60 39.50 4.32 5160.70 118.35 493.70
CIPLA LTD 1353.85 28.73 3.17 109370.14 1165.55 1672.20
FERMENTA BIOTECH LTD. 338.20 14.92 2.44 995.36 256.40 399.00
GLAXOSMITHKLINE PHARMA LT 2332.85 41.07 17.42 39519.89 2088.00 3500.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 22.24 4.09 243.69 23.12 38.85
AMRUTAJAN HEALTH LTD 546.70 24.50 4.26 1580.54 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8406.60 109.79 24.07 21016.50 7630.00 9850.00
BLISS GVS PHARMA LTD. 486.60 52.49 4.46 5160.70 118.35 493.70

Zenlabs Ethica Limited shareholding pattern

Holding
47.03%
52.96%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

Zenlabs Ethica Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
34.50 -0.69 redarrow
red-green-graph indicator
5 Bearish
11 Bullish
  • 5 Days 34.50
  • 26 Days 33.10
  • 10 Days 34.60
  • 50 Days 30.20
  • 12 Days 34.60
  • 100 Days 27.40
  • 20 Days 33.90
  • 200 Days 27.30
33.70 PIVOT
First Support 32.65 First Resistance 35.78 Second Support 30.57 Second Resistance 36.83 Third Support 29.52 Third Resistance 38.91
RSI 55.51 ADX 30.24 MACD 1.47 Williams % R -65.51 Commodity Channel Index (CCI) -23.38
Date 2026-06-19 Week 3078.00 Same Day 1053.00 Month 9597.00
1 Year 1.05 3 Year 0.75
Over 1 Month
13.86% down
Over 1 Year
3.66% down
Over 3 Months
80.81% down
Over 3 Years
-7.78% down
Over 6 Months
75.39% down
Over 5 Years
-0.56% down

Zenlabs Ethica Limited Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
29 Jul 2022 0.25 Interim 01 Aug 2022 Equity shares
20 Sep 2017 0.25 Final 22 Sep 2017 Equity shares
Ex-Date Ex-Bonus Ratio
13 Oct 2018 11 Oct 2018 1:20

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Zenlabs Ethica Ltd?

Answer Field

Zenlabs Ethica Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 34.50 as on Jun 19 2026 03:07 PM.

What is the Market Cap of Zenlabs Ethica Ltd Share?

Answer Field

The market cap of Zenlabs Ethica Ltd for NSE ₹ 0.00 & for BSE ₹ 22.50 as on Jun 19 2026 03:07 PM.

What is the 52 Week High and Low of Zenlabs Ethica Ltd?

Answer Field

The 52 Week High and Low of Zenlabs Ethica Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 39.99 and ₹ 16.50.

What is 1 year return for Zenlabs Ethica Ltd?

Answer Field

The 1 year returns on the stock has been 3.66%.

What is the P/E Ratio of Zenlabs Ethica Ltd Share?

Answer Field

As on Jun 19 2026 03:07 PM the price-to-earnings (PE) ratio for Zenlabs Ethica Ltd share is -11.62.

What is the PB ratio of Zenlabs Ethica Ltd Share?

Answer Field

As on Jun 19 2026 03:07 PM, the price-to-book (PB) ratio for Zenlabs Ethica Ltd share is 13.07.

How to Buy Zenlabs Ethica Ltd Share?

Answer Field

You can trade in Zenlabs Ethica Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Zenlabs Ethica Ltd Share on Bajaj Broking App?

Answer Field

To buy Zenlabs Ethica Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Zenlabs Ethica Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|